Bone Loss: Clinical Trials

2 trials for Bone Loss, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Unknown 2

Follow Bone Loss: new trials by email Literature Review of Bone Loss trials Research Report on Bone Loss

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model
Biphasic bioceramic of tricalcium phosphate and hydroxyapatite with simvastatin, Bovine Hydroxyapatite - Bone Loss, Regenerative Inflammation
Phase 4UnknownMario Pérez Sayáns302024-03-022024-04-03
BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) Study
B/F/TAF, TDF/3TC/EFV or DTG or NVP, DMPA - Bone Loss
Phase 4UnknownMU-JHU CARE3302019-12-032023-04-07

Narrower conditions

Bone Diseases, Metabolic (2)

Broader conditions

Bone Diseases (2)  ·  Metabolic Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Nutritional and Metabolic Diseases (2)

Interventions

Bio-Oss (1)  ·  Durapatite (1)  ·  Medroxyprogesterone Acetate (1)  ·  N,N-dimethyl-4-anisidine (1)  ·  Nevirapine (1)  ·  Simvastatin (1)  ·  bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1)  ·  dolutegravir (1)

Sponsors

MU-JHU CARE (1)  ·  Mario Pérez Sayáns (1)

Countries

Spain (1)  ·  Uganda (1)

Top investigators

Flavia Kiweewa Matovu, MBChB, MSc (1)